A new NIAID-funded study shows how inconsistent malaria control measures in East Africa could be aiding the emergence of drug-resistant mutations in the primary parasite that causes malaria.
A team of NIAID-led researchers has identified a mechanism in mice in which the immune system and commensal bacteria help repair damaged sensory neurons within the skin. They hope their findings could lead to therapies that stimulate recovery in people following skin injury and limit damage from chemotherapy and chronic diseases.
Candida auris, is an emerging healthcare-associated infection of growing public health concern. NIAID supports several researchers who are asking fundamental questions about the biology of C. auris. Today’s NIAID Now post features insights from NIAID-funded researchers, Jeniel Nett, M.D., Ph.D., associate professor of medicine and medical microbiology and immunology at University of Wisconsin-Madison, and Christina Cuomo, Ph.D., associate director of the Genomic Center of Infectious Diseases at the Broad Institute of Massachusetts Institute of Technology and Harvard University.
A new study in mice from NIAID scientists now shows that toxins from Staphylococcus aureus alarm the immune system hours earlier than previously known.
Antimicrobials such as antibiotics, antivirals, and antifungal drugs are crucial tools in the fight against disease-causing microbes. However, resistance of microbes to these life-saving medicines is a growing global public health dilemma. In fact, the Centers for Disease Control and Prevention (CDC) reports that more than 2.8 million infections and over 35,000 deaths are caused by antibiotic...
A new study from NIAID's Intramural research program provides an update on research into using a probiotic to treat bacterial gut infections.
A NIAID-sponsored study has shown that short-course antibiotic treatment is superior to standard treatment of community-acquired pneumonia in children.